Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Valentina Elisabetta Bounous, Silvia Actis, Roberta Rosso, Margherita Giorgi, Lara Tiranini, Rossella Elena Nappi & Nicoletta Biglia. (2023) No-daily hormonal contraception today: general overview and application in specific clinical settings. Gynecological Endocrinology 39:1.
Read now
Read now
Gabriele S. Merki-Feld, Sven Skouby, David Serfaty, Medard Lech, Johannes Bitzer, Pier Giorgio Crosignani, Angelo Cagnacci & Regine Sitruk-Ware. (2015) European Society of Contraception Statement on Contraception in Obese Women. The European Journal of Contraception & Reproductive Health Care 20:1, pages 19-28.
Read now
Read now
Johan Verhaeghe. (2010) Hormonal contraception in women with the metabolic syndrome: A narrative review. The European Journal of Contraception & Reproductive Health Care 15:5, pages 305-313.
Read now
Read now
Articles from other publishers (29)
Franco Giraudo, Abril Salinas, Paulina M Merino, Germán Iñiguez, Patricia López, Andrea Castro, María Cecilia Lardone, Gabriel Cavada, Fernando Cassorla & Ethel Codner. (2023) Subdermal progestin implant and an oral combined hormonal contraceptive in youth with type 1 diabetes. Journal of Pediatric and Adolescent Gynecology.
Crossref
Crossref
. (2022) FSRH Guideline (August 2022) Progestogen-only Pills. BMJ Sexual & Reproductive Health 48:Suppl 1, pages 1-75.
Crossref
Crossref
Vanessa Preumont. (2022) Contraception and diabetes: Which modalities should we consider in 2021?. Annales d'Endocrinologie.
Crossref
Crossref
Paulina M. Merino & Ethel Codner. (2022) Contraception for Adolescents and Young Women with Type 2 Diabetes–Specific Considerations. Current Diabetes Reports 22:2, pages 77-84.
Crossref
Crossref
Meletios P. Nigdelis & Dimitrios G. Goulis. 2022. Comprehensive Clinical Approach to Diabetes During Pregnancy. Comprehensive Clinical Approach to Diabetes During Pregnancy
395
408
.
Eliza Buyers, Amy E. Sass, Cameron D. Severn, Laura Pyle & Melanie Cree-Green. (2021) Twelve-month Continuation of the Etonogestrel Implant in Adolescents With Polycystic Ovary Syndrome. Journal of Pediatric and Adolescent Gynecology 34:1, pages 33-39.
Crossref
Crossref
Abril Salinas, Paulina M. Merino, Franco Giraudo & Ethel Codner. (2020)
Long‐acting
contraception in adolescents and young women with type 1 and type 2 diabetes
. Pediatric Diabetes 21:7, pages 1074-1082.
Crossref
Crossref
Johannes Bitzer. 2020. Obesity and Gynecology. Obesity and Gynecology
67
73
.
Agnieszka Jurga-Karwacka & Johannes Bitzer. 2020. Obesity and Gynecology. Obesity and Gynecology
57
65
.
Anita L. Nelson. 2020. The Handbook of Contraception. The Handbook of Contraception
305
335
.
. (2019) FSRH Guideline (April 2019) Overweight, Obesity and Contraception. BMJ Sexual & Reproductive Health 45:Suppl 2, pages 1-69.
Crossref
Crossref
Maurizio Guida, Manuela Farris, Carmen Imma Aquino, Elena Rosato, Lucio M. A. Cipullo & Carlo Bastianelli. (2019) Nexplanon Subdermal Implant: Assessment of Sexual Profile, Metabolism, and Bleeding in a Cohort of Italian Women. BioMed Research International 2019, pages 1-6.
Crossref
Crossref
F. Galtier, C. Brunet & J. Bringer. 2019. Diabetologie. Diabetologie
429
439
.
Eleanor Bimla Schwarz, Monica Y. Braughton, Julie Cross Riedel, Susannah Cohen, Julia Logan, Mike Howell & Heike Thiel de Bocanegra. (2017) Postpartum care and contraception provided to women with gestational and preconception diabetes in California's Medicaid program. Contraception 96:6, pages 432-438.
Crossref
Crossref
Mimi S. Mukherjee, Valerie A. Coppenrath & Bree A. Dallinga. (2015) Pharmacologic Management of Types 1 and 2 Diabetes Mellitus and Their Complications in Women of Childbearing Age. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35:2, pages 158-174.
Crossref
Crossref
F. Galtier, C. Brunet & J. Bringer. 2014. Diabétologie. Diabétologie
315
325
.
Meredith Macrae Warden, Jody Steinauer & Elizabeth Harleman. 2014. Contraception for the Medically Challenging Patient. Contraception for the Medically Challenging Patient
55
68
.
Meredith Macrae Warden, Jody Steinauer & Elizabeth Harleman. 2014. Contraception for the Medically Challenging Patient. Contraception for the Medically Challenging Patient
55
68
.
Nicole M. Bender, Penina Segall-Gutierrez, Sandy Oliver Lopez Najera, Frank Z. Stanczyk, Martin Montoro & Daniel R. MishellJr.Jr.. (2013) Effects of progestin-only long-acting contraception on metabolic markers in obese women. Contraception 88:3, pages 418-425.
Crossref
Crossref
L. Bricaire-Dubreuil. 2013. La Contraception en Pratique. La Contraception en Pratique
68
72
.
Donald E. Greydanus, Helen D. Pratt & Dilip R. Patel. (2012) Concepts of Contraception for Adolescent and Young Adult Women with Chronic Illness and Disability. Disease-a-Month 58:5, pages 258-320.
Crossref
Crossref
L.F. PallardoA CanoI CristobalM.A. BlancoM LozanoI Lete. (2012) Hormonal Contraception and Diabetes. Clinical Medicine Insights: Women's Health 5, pages CMWH.S9934.
Crossref
Crossref
Jennifer E. Lykens & Jane E.D. Broecker. (2011) Contraceptive options for women with metabolic syndrome. Osteopathic Family Physician 3:3, pages 88-98.
Crossref
Crossref
David Serfaty. 2011. Contraception. Contraception
338
455
.
V. Kerlan. (2010) Postpartum and contraception in women after gestational diabetes. Diabetes & Metabolism 36:6, pages 566-574.
Crossref
Crossref
V. Kerlan. (2010) Post-partum et contraception chez les femmes ayant eu un diabète gestationnel. Journal de Gynécologie Obstétrique et Biologie de la Reproduction 39:8, pages S289-S298.
Crossref
Crossref
Penina Segall-Gutierrez & Siri L. Kjos. 2010. A Practical Manual of Diabetes in Pregnancy. A Practical Manual of Diabetes in Pregnancy
230
241
.
F. Galtier, C. Brunet & J. Bringer. 2010. Diabétologie. Diabétologie
305
316
.
Monique Hedderson. 2010. Gestational Diabetes During and After Pregnancy. Gestational Diabetes During and After Pregnancy
317
329
.